Pediatric antiphospholipid antibodies and antiphospholipid syndrome

Seminars in Thrombosis and Hemostasis

Volumn 34, Issue 3, 2008, Pages 274-281

  Hune, Beverley J ^a,b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Children

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CARDIOLIPIN ANTIBODY; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; MATERNAL ANTIBODY; PHOSPHOLIPID ANTIBODY; RITUXIMAB; WARFARIN;

ANTIBODY DETECTION; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHILD HEALTH; CHILDHOOD DISEASE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DISEASE REGISTRY; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; HUMAN; INTERNATIONAL NORMALIZED RATIO; JUVENILE RHEUMATOID ARTHRITIS; LOADING DRUG DOSE; PREVALENCE; PRIORITY JOURNAL; PROTHROMBIN TIME; REYE SYNDROME; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS PREVENTION; TREATMENT DURATION;

ADMINISTRATION, ORAL; ADOLESCENT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; BRAIN ISCHEMIA; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; INFECTION; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREVALENCE; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 50249159494     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0028-1082271     Document Type: Article

References (91)

1. Harris EN, Gharavi AE, Boey ML, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;2:1211-1214
2. Hughes GRV, Harris AE, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986;13:486-489
3. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-300
4. Wise RC, Todd JK. Spontaneous lower extremity venous thrombosis in children. Am J Dis Child 1973;126:766-769
5. Andrew M, David M, Adams M, et al. Venous thromboembolic complications (VTE) in children: first analysis of the Canadian Registry of VTE. Blood 1994;83:1251-1257
6. Nowak-Gottl U, Koch HG, Aschka I, et al. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol 1996;92:992-998
7. Broderick J, Talbot GT, Prenger E. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol 1993;8:250-255
8. Williams LS, Garg BP, Cohen M, et al. Subtypes of ischemic stroke in children and young adults. Neurology 1997;49:1541-1545
9. Avcin T, Silverman ED. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Lupus 2007;16:627-633
10. Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544-1547
11. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306
12. Vaarala O, Palosuo T, Kleemola M, Aho K. Anticardiolipin response in acute infections. Clin Immunol Immunopathol 1986;41:8-15
13. Kurugol Z, Vardar F, Ozkinay F, Kavakli K, Ozkinay C. Lupus anticoagulant and protein S deficiency in otherwise healthy children with acute varicella infection. Acta Paediatr 2000;89:1186-1189
14. Manco-Johnson MJ, Nuss R, Key N, et al. Lupus anticoagulant and protein S deficiency in children with post varicella purpura fulminans or thrombosis. J Pediatr 1996;128:319-323
15. Levi M. Measuring activated protein C in plasma to assess its role as a critical modulator of coagulation and inflammation. J Thromb Haemost 2003;1:643-644
16. Rapizzi E, Ruffati A, Tonello M, et al. Correction of age of anticardiolipin antibodies cut-off points. J Clin Lab Anal 2000;14:87-90
17. Caporali R, Ravelli A, De Gennaro F, Neirotti G, Montecucco C, Martini A. Prevalence of anticardiolipin antibodies in juvenile arthritis. Ann Rheum Dis 1991;50:599-601
18. Siamopoulou-Mavridou AMavradis AK, Terzoglou C, Filopoulou S, Athanasiadou S, Tzioufas AG. Autoantibodies in Greek juvenile chronic arthritis patients. Clin Exp Rheumatol 1991;9:647-652
19. Gattorno M, Buoncompagni A, Molinari AC, et al. Antiphospholipid antibodies in paediatric systemic lupus erythematosis, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome. Br J Rheumatol 1995;34:873-881
20. Kontianes S, Miettinen A, Sepala I, Verkasalo M, Maenpaa J. Antiphospholipid antibodies in children. Acta Paediatr 1996;85:614-615
21. Serra CRB, Rodrigues SH, Silva NP, Szatajnbok FR, Andrade LEC. Clinical significance of anticardiolipin antibodies in juvenile idiopathic arthritis. Clin Exp Rheumatol 1999;17:375-380
22. Avcin T, Ambrozic A, Kuher H, Kveder T, Rozman B. Anticardiolipin and anti-β2GPL antibodies in sera of 61 apparently healthy children at regular preventive visits. Rheumatology 2001;40:565-573
23. Ambrozic A, Avein T, Ichikawa K, et al. Anti-β2GPI antibodies in children with atopic dematitis. Int Immunol 2002;14:823-830
24. Male C, Lechner K, Eichinger S, et al. Clinical significance of lupus anticoagulants in children. J Pediatr 1999;134:199-205
25. Gallistl S, Muntean W, Leschnik B, Meyers W. Longer aPPT values in healthy children than in adults: no single cause. Thromb Res 1997;88:355-359
26. Siemens HJG, Gutsche S, Bruckner S, Bucsky P, Katus HA. Antiphospholipid antibodies in children without and in adults with and without thrombophilia. Thromb Res 2000;98:241-247
27. Aguilar Franco C, Lucia Cuesta J. Antiphospholipid antibodies in asymptomatic pediatric patients [in Spanish]. An Esp Pediatr 2001;54:444-449
28. Martinuc-Porobic J, Avein T, Bozic B, et al. Antiphospholipid antibodies following vaccination with recombinant hepatitis B vaccine. Clin Exp Immunol 2005;142:377-380
29. Ravelli A, Martini A. Antiphospholipid antibody syndrome in pediatric patients. Rheum Dis Clin North Am 1997;23:657-676
30. Tucker LB. Antiphospholipid antibodies and antiphospholipid syndromes in children. In: Khamashta MA, ed. Hughes Syndrome, Antiphospholipid Syndrome. London, England: Springer; 2000:155-166
31. Uysal Z, Dogu F, Kurekci AE, et al. Recurrent arterial thrombosis in a child: primary antiphospholipid antibody syndrome. Pediatr Hematol Oncol 2002;19:59-66
32. Manco-Johnson MJ, Nuss R. Lupus anticoagulant in children with thrombosis. Am J Hematol 1995;48:240-243
33. Falcini F, Taccetti G, Ermini M, Trapani S, Matucci Cerinic M. Catastrophic antiphospholipid antibody syndrome in pediatric systemic lupus erythematosus. J Rheumatol 1997;24:389-392
34. Angelini L, Zibordi F, Zorzi G, et al. Neurological disorders, other than stroke, associated with antiphospholipid antibodies in childhood. Neuropediatrics 1996;27:149-153
35. Angelini L, Granata T, Zibordi F, Binelli S, Zorgi G, Besana C. Partial seizures associated with antiphospholipid antibodies in childhood. Neuropediatrics 1998;29:249-253
36. Tucker LB. Antiphospholipid syndrome in childhood: the great unknown. Lupus 1994;3:367-369
37. Ravelli A, Caporali R, Di Fuccia G, Zonta L, Montecucco C, Martini A. Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Arch Pediatr Adolesc Med 1994;148:398-402
38. Seaman DE, Londino V, Kwoh CK, Medsger TA, Manzi S. Antiphospholipid antibodies in pediatric systemic lupus erythematosis. Pediatrics 1995;96:1040-1045
39. Shergy WJ, Kredich DW, Pisetsky DS. The relationship of anticardiolipin antibodies to disease manifestations in pediatric systemic lupus erythematosis. J Rheumatol 1988;15:1389-1394
40. Montes de Oca MA, Babron MC, Bletry O, et al. Thrombosis in systemic lupus erythematosus: a French collaborative study. Arch Dis Child 1991;66:713-717
41. Molta C, Meyer O, Dosquet C, et al. Childhood-onset systemic lupus erythematosis: antiphospholipid antibodies in 37 patients and their first-degree relatives. Pediatrics 1993;92:849-853
42. Massengill SF, Hedrick C, Ayoub EM, Sleasman JW, Kao KJ. Antiphospholipid antibodies in pediatric lupus nephritis. Am J Kidney Dis 1997;29:355-361
43. Berube C, Mitchell L, Silverman E, et al. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosis: a cross-sectional study. Pediatr Res 1998;44:351-356
44. Gedalia A, Molina JF, Garcia CO, Doggett S, Espinoza LR, Gharavi AE. Anticardiolipin antibodies in childhood rheumatic disorders. Lupus 1998;7:551-553
45. Sugita K, Sato Y, Owada Y, Kurosawa H, Eguchi M. Antiphospholipid antibody syndrome followed by systemic lupus erythematosus in a young male with clinical manifestations since infancy. Pediatr Int 2001;43:563-564
46. Avcin T, Cimaz R, Meroni PL. Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations. Lupus 2002;11:4-10
47. Southwood TR, Roberts-Thomson PJ, Ahern MJ, et al. Autoantibodies in patients with juvenile chronic arthritis and their immediate family members. Ann Rheum Dis 1990;49:968-972
48. Avcin T, Benseler SM, Tyrrell PN, Cucnik S, Silverman ED. Longitudinal follow-up study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus (in press). Arthritis Rheum 2008;59:206-213
49. Levy DM, Massicotte MP, Harvey E, Herbert D, Silverman ED. Thromboembolism in paediatric lupus patients. Lupus 2003;12:741-746
50. Male C, Mitchell L, Julian J, et al. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus. Blood 2001;97:844-849
51. Male C, Foulon D, Hoogendoorn H, et al. Predictive value of persistent versus transient antiphospholipid antibody subtype for the risk of thrombotic events in pediatric patients with systemic lupus erythemasus. Blood 2005;106:4152-4158
52. Miller DJ, Maisch SA, Perez MD, Kearney DL, Feltes TF. Fatal myocardial infarction in an 8-year-old girl with systemic lupus erythematosus, Raynaud's phenomenon, and secondary antiphospholipid syndrome. J Rheumatol 1995;22:768-773
53. Angelini L, Ravelli A, Caporali R, Rumi V, Nardocci N, Martini A. High prevalence of antiphospholipid antibodies in children with idiopathic cerebral ischemia. Pediatrics 1994;94:500-503
54. Schöning M, Klein R, Krageloh-Mann I, et al. Antiphospholipid antibodies in cerebrovascular ischemia and stroke in childhood. Neuropediatrics 1994;25:8-14
55. Takanashi J, Sugita K, Miyazato S, Sakao E, Miyamoto H, Niimi H. Antiphospholipid antibody syndrome in childhood strokes. Pediatr Neurol 1995;13:323-326
56. Baca V, Garcia-Ramirez R, Ramirez-Lacayo M, Marquez-Enriquez L, Martinez I, Lavalle C. Cerebral infarction and antiphospholipid syndrome in children. J Rheumatol 1996;23:1428-1431
57. Kenet G, Sadetzki S, Murad H, et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000;31:1283-1288
58. Pilarska E. The significance of antiphospholipid antibodies in ischemic stroke in children in light of the most current studies [in Polish]. Przegl Lek 2001;58:22-24
59. deVeber G, Andrews M, Adams C, et al for the Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med 2001;345:417-423
60. Vlachoyiannopoulos PG, Dimou G, Siamopoulou-Mavridou A. Chorea as a manifestation of the antiphospholipid syndrome in childhood. Clin Exp Rheumatol 1991,9:303-305
61. Besbas N, Damargue I, Ozen S, Aysun S, Saatci U. Association of antiphospholipid antibodies with systemic lupus erythematosus in a child presenting with chorea: a case report. Eur J Pediatr 1994;153:891-893
62. Okun MS, Jummani RR, Carney PR. Antiphospholipid-associated recurrent chorea and ballism in a child with cerebral palsy. Pediatr Neurol 2000;23:62-63
63. Al-Matar M, Jaimes J, Malleson P. Chorea as the presenting clinical feature of primary antiphospholipid syndrome in childhood. Neuropediatrics 2000;31:107-108
64. Hasegawa M, Yamashita J, Yamashita T, Ikeda K, Fujishima Y, Yamazaki M. Spinal cord infarction associated with primary antiphospholipid syndrome in a young child. Case report. J Ncurosurg 1993;79:446-450
65. Besbas N, Anlar B, Apak A, Kansu T. Optic neuropathy in primary antiphospholipid syndrome in childhood. J Child Neurol 2001;16:690-693
66. Rumi V, Angelini L, Scioli V, D'Angelo A, Besana C. Primary antiphospholipid syndrome and neurologic events. Pediatr Neurol 1993;9:473-475
67. Agarwal KS, Puliyel JM, Khanduri U. Sudden onset profound deafness in association with antiphospholipid antibodies in a child with SLE. Indian Pediatr 2000;37:1274-1276
68. Booth F, Yanofsky R, Ross IB, Lawrence P, Oen K. Primary antiphospholipid syndrome with moyamoya-like vascular changes. Pediatr Neurosurg 1999;31:45-48
69. Harel L, Sandborg C, Lee Tvon Scheven E. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. J Rheumatol 2006;33:1873-1877
70. Avcin T, Benseler SM, Tyrell PN, Cucnik S, Silverman ED. A follow-up study of antiphospholipid antibodies and associated neurophychiatric manifestations in 137 children with systemic lupus erythematosus. Arthritis Rheum 2008;59:206-213
71. Eriksson K, Peltola J, Keranen T, Haapala AM, Koivikko M. High prevalence of antiphospholipid antibodies in children with epilepsy: a controlled study of 50 cases. Epilepsy Res 2001;46:129-137
72. Purandare A, Godil MA, Prakash D, Parker R, Zerah M, Wilson TA. Spontaneous adrenal hemorrhage associated with transient antiphospholipid antibody in a child. Clin Pediatr (Phila) 2001;40:347-350
73. Becton DL, Stine KC. Transient lupus anticoagulants associated with hemorrhage rather than thrombosis: the hemorrhagic lupus anticoagulant syndrome. J Pediatr 1997;130:998-1000
74. Yacobovich JR, Uziel Y, Friedman Z, Radnay J, Wolach B. Diffuse muscular haemorrhage as presenting sign of juvenile systemic lupus erythematosus and lupus anticoagulant hypoprothrombinaemia syndrome. Rheumatology 2001;40:585-587
75. Boffa MC, Lachassinne E. Infant perinatal thrombosis and antiphospholipid antibodies: a review. Lupus 2007;16:634-641
76. Ohtomo Y, Nagaoka R, Watanabe H, Kaneko K, Ohyama S, Yamashiro Y. Non-lupus nephropathy associated with antiphospholipid antibodies. Pediatr Nephrol 2000;15:136-138
77. Minisola G, Porzio V, Bancheri C, Ceralli F, Carnabuci A, Onetti Muda A. Atypical renal onset and involvement in primary antiphospholipid syndrome in a child. Clin Exp Rheumatol 1998;16:102-104
78. Monastiri K, Selmi H, Tabarki B, Yacoub M, Mahjoub T, Essoussi AS. Primary antiphospholipid syndrome presenting as complicated Henoch-Schonlein purpura. Arch Dis Child 2002;86:132-133
79. Rongioletti F, Ghio L, Ginevri F, et al. Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 1999;140:948-951
80. Monagle P, Michelson AD, Bovill W, Andrews M. Antithrombioic therapy in children. Chest 2001;119:344S-370S
81. Massicotte P, Adams M, Marzinotto V, Brooker LA, Andrew M. Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr 1996;128:313-318
82. Burak CR, Bowen MD, Barron TF. The use of enoxaparin in children with acute, nonhemorrhagic ischemic stroke. Pediatr Neurol 2003;29:295-298
83. Dix D, Andrew M, Marzinotto V, et al. The use of low-molecular-weight heparin in pediatric patients: a prospective cohort study. J Pediatr 2000;136:439-445
84. Punzalan RC, Hillery CA, Montgomery RR, Scott JP, Gill JC. Low-molecular-weight heparin in thrombotic disease in children and adolescents. J Pediatr Hematol Oncol 2000;22:137-142
85. Albisetti M, Andrew M. Low molecular weight heparin in children. Eur J Pediatr 2002;161:71-77
86. Erkan D, Lockshin MD. New treatments for antiphospholipid syndrome. Rheum Dis Clin North Am 2006;32:129-148
87. Buck ML. Anticoagulation with warfarin in infants and children. Ann Pharmacother 1996;30:1316-1322
88. Doyle JJ, Koren G, Cheng MY, Blanchette VS. Anticoagulation with sodium warfarin in children: effect of a loading regimen. J Pediatr 1988;113:1095-1097
89. Crowther MA, Ginsberg JS, Julian J, et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 2003;349:1133-1138
90. Finazzi G, Marchioli R, Brancaccio V, et al. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost 2005;3:848-853
91. Khamashta MA, Hunt BJ. Moderate-dose oral anticoagulant therapy in patients with the antiphospholipid syndrome? J Thromb Haemost 2005;3:844-845